Cargando…
Retrospective comparison of death or neurodevelopmental outcomes in extremely low birth weight preterm infants following different management options of haemodynamically significant patent ductus arteriosus
BACKGROUND: Optimal management of haemodynamically significant patent ductus arteriosus (HsPDA) in premature babies remains controversial. Our aim is to compare death and/or adverse neurodevelopmental outcomes in extremely low birth weight (ELBW) infants with HsPDA who were managed with conservative...
Autores principales: | Wu, Jania Jia-Ying, Niduvaje, Krishnamoorthy, Lee, Le ye, Amin, Zubair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523346/ https://www.ncbi.nlm.nih.gov/pubmed/34663266 http://dx.doi.org/10.1186/s12887-021-02920-9 |
Ejemplares similares
-
Plasma Amino Acid Concentrations at Birth and Patent Ductus Arteriosus in Very and Extremely Preterm Infants
por: Huizing, Maurice J., et al.
Publicado: (2021) -
Conservative Non-intervention Approach for Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants
por: Sung, Se In, et al.
Publicado: (2020) -
B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants
por: Mine, Kenji, et al.
Publicado: (2013) -
Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants
por: Arlettaz, Romaine
Publicado: (2017) -
Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
por: Coviello, Caterina, et al.
Publicado: (2020)